-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

US Perspective

Program: General Sessions
Session: ASH/EHA Joint Symposium
Sunday, December 6, 2015, 12:30 PM-1:30 PM
Hall D, Level 2 (Orange County Convention Center)

Ross L. Levine, MD

Memorial Sloan Kettering Cancer Center, New York, NY

Disclosures: Levine: Loxo Oncology: Membership on an entity’s Board of Directors or advisory committees ; CTI BioPharma: Membership on an entity’s Board of Directors or advisory committees ; Foundation Medicine: Consultancy .

See more of: ASH/EHA Joint Symposium
See more of: General Sessions
Previous Presentation | Next Presentation >>